Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0240671B2 - 11FUENIRUU1HHPIRAZORO * 3 * 44B * PIRAJINJUDOTAI - Google Patents
[go: Go Back, main page]

JPH0240671B2 - 11FUENIRUU1HHPIRAZORO * 3 * 44B * PIRAJINJUDOTAI - Google Patents

11FUENIRUU1HHPIRAZORO * 3 * 44B * PIRAJINJUDOTAI

Info

Publication number
JPH0240671B2
JPH0240671B2 JP1722782A JP1722782A JPH0240671B2 JP H0240671 B2 JPH0240671 B2 JP H0240671B2 JP 1722782 A JP1722782 A JP 1722782A JP 1722782 A JP1722782 A JP 1722782A JP H0240671 B2 JPH0240671 B2 JP H0240671B2
Authority
JP
Japan
Prior art keywords
group
phenyl
substituted
formula
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP1722782A
Other languages
Japanese (ja)
Other versions
JPS58135887A (en
Inventor
Shinichi Suzuki
Kunitomo Suzuki
Hiromitsu Pponda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP1722782A priority Critical patent/JPH0240671B2/en
Priority to US06/428,016 priority patent/US4460773A/en
Priority to DE19823237243 priority patent/DE3237243A1/en
Publication of JPS58135887A publication Critical patent/JPS58135887A/en
Publication of JPH0240671B2 publication Critical patent/JPH0240671B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は、優れた抗腫瘍作用もしくは抗ウイル
ス作用を有する下記式(1) (但し、R1及びR2は、それぞれ水素原子;アル
キル基;ヒドロキシ基,カルボキシル基,ハロゲ
ン原子,アルキルアミノ基,フエニル基,ニトロ
フエニル基,ハロゲノフエニル基もしくはアルキ
ルフエニル基により置換されたアルキル基;シク
ロアルキル基;アルキル基により置換されたシク
ロアルキル基;又はアミノ基;又はR1とR2はそ
れらが結合する窒素原子と共に酸素原子を介し又
は介することなく飽和複素環(含窒素飽和複素
環)を形成しているものであり、該複素環にはカ
ルボキシル基が置換していてもよい。) で示される新規1―フエニル―1H―ピラゾロ
〔3,4―b〕ピラジン誘導体に関する。 従来より、抗腫作用や抗ウイルス作用を有する
種々の物質が開発され、提案されているが、本発
明者らも抗腫瘍作用や抗ウイルス作用に優れ、抗
腫瘍剤或いは抗ウイルス剤として使用することが
できる化合物につき鋭意研究を行なつているう
ち、5―クロロ―1―フエニル―1H―ピラゾロ
〔3,4―b〕ピラジンを
The present invention provides the following formula (1) having excellent antitumor or antiviral effect: (However, R 1 and R 2 are each a hydrogen atom; an alkyl group; an alkyl group substituted with a hydroxy group, a carboxyl group, a halogen atom, an alkylamino group, a phenyl group, a nitrophenyl group, a halogenophenyl group, or an alkylphenyl group; Cycloalkyl group; cycloalkyl group substituted by an alkyl group; or amino group; or R 1 and R 2 are saturated heterocycles (nitrogen-containing saturated heterocycles) together with the nitrogen atom to which they are bonded, with or without an oxygen atom 1-Phenyl-1H-pyrazolo[3,4-b]pyrazine derivatives. Conventionally, various substances having antitumor and antiviral effects have been developed and proposed, and the present inventors also found that they have excellent antitumor and antiviral effects and are used as antitumor or antiviral agents. While conducting intensive research on compounds that can

【式】(但し、R1 及びR2は前記の意味を示す)で示される含窒素
化合物と反応させる等の方法により、前記(1)式で
示される新規化合物1―フエニル―1H―ピラゾ
ロ〔3,4―b〕ピラジン誘導体が得られると共
に、これらの化合物が優れた抗腫瘍作用もしくは
抗ウイルス作用を有し、抗腫瘍剤或いは抗ウイル
ス剤として効果的に使用され得ることを知見し、
本発明をなすに至つた。 以下、本発明につき更に詳しく説明する。 本発明に係る新規化合物1―フエニル―1H―
ピラゾロ〔3,4―b〕ピラジン誘導体は、上述
した(1)式、即ち (但し、R1及びR2は、それぞれ水素原子;アル
キル基;ヒドロキシ基,カルボキシル基,ハロゲ
ン原子,アルキルアミノ基,フエニル基,ニトロ
フエニル基,ハロゲノフエニル基もしくはアルキ
ルフエニル基により置換されたアルキル基;シク
ロアルキル基;アルキル基により置換されたシク
ロアルキル基;又はアミノ基;又はR1とR2はそ
れらが結合する窒素原子と共に酸素原子を介し又
は介することなく飽和複素環(含窒素飽和複素
環)を形成しているものであり、該複素環にはカ
ルボキシル基が置換していてもよい。) で示される化学構造式を有するものである。 ここで(1)式において、アルキル基としてはメチ
ル基、エチル基、プロピル基、ブチル基、ペンチ
ル基、ヘキシル基等の直鎖アルキル基、1―メチ
ルエチル基、2―メチルプロピル基、1―メチル
プロピル基、1,1―ジメチルエチル基、2―メ
チルブチル基、3―メチルブチル基、1,1―ジ
メチルプロピル基、2,2―ジメチルプロピル
基、1―メチルブチル基、1―メチルペンチル
基、2―メチルペンチル基、3―メチルペンチル
基、4―メチルペンチル基、1,3―ジメチルブ
チル基、1,2―ジメチルブチル基、2,3―ジ
メチルブチル基、2,2―ジメチルブチル基、
3,3―ジメチルブチル基、1―エチルブチル
基、2―エチルブチル基、1―メチルヘキシル
基、1―メチルヘプチル基等の分枝鎖アルキル基
などが挙げられる。 また、置換アルキル基としては、上記アルキル
基の1又は2以上の水素原子をヒドロキシ基、カ
ルボキシ基、ハロゲン、低級アルキルアミノ基、
フエニル基、置換フエニル基で適宜置換したもの
が挙げられる。この場合、ハロゲンとしてはフツ
素、塩素、臭素等が挙げられ、また低級アルキル
アミノ基のアルキル基としてはメチル基、エチル
基、プロピル基、イソプロピル基、ブチル基、イ
ソブチル基、ペンチル基、イソペンチル基、ネオ
ペンチル基、ヘキシル基等の炭素数1〜6の直鎖
又は分枝鎖アルキル基が挙げられる。更に、置換
フエニル基はその水素原子の1又は2以上をメチ
ル基、エチル基、プロピル基、イソプロピル基、
ブチル基、イソブチル基、ペンチル基、イソペン
チル基、ネオペンチル基、ヘキシル基等の直鎖又
は分枝鎖の炭素数1〜6の低級アルキル基、フツ
素、塩素、臭素等のハロゲン、ニトロ基、カルボ
キシル基などが挙げられる。 また、シクロアルキル基としてはシクロペンチ
ル基、シクロヘキシル基等が挙げられる。 なお、シクロアルキル基は、その水素原子の1
又は2以上をメチル基、エチル基、プロピル基、
イソプロピル基、ブチル基、イソブチル基、ペン
チル基、イソペンチル基、ネオペンチル基、ヘキ
シル基等の直鎖又は分枝鎖の炭素数1〜6の低級
アルキル基により置換されていてもよい。 更に、含窒素飽和複素環としてはピロリジニ
ル、イミダゾリジニル、ピラゾリジニル、ピペリ
ジニル、ピペラジニル、モルホリニル等が挙げら
れる。なお、該複素環にはカルボキシル基が置換
していてもよい。 前記(1)式の化合物は、5―ハロゲノ―1―フエ
ニル―1H―ピラゾロ〔3,4―b〕ピラジンに
対し、該当するアミン又は含窒素複素環を反応さ
せることにより合成することができる(下記反応
式a参照)。 (但し、Xはハロゲン原子、R1及びR2は前記の
意味を示す。) なお、(2)式においてXがクロル原子である5―
クロロ―1―フエニル―1H―ピラゾロ〔3,4
―b〕ピラジン(式(2′))は下記反応式bにそ
の一例を示すように、(3)式の5―アミノ―1―フ
エニル―ピラゾール―4―カルボン酸を例えば
180℃に加熱して脱炭酸を行ない、(4)式の5―ア
ミノ―1―フエニル―ピラゾールを合成し、これ
を乾燥塩酸存在下エタノール中で亜硝酸イソアミ
ルと反応させて(5)式の5―アミノ―4―ニトロソ
―1―フエニル―ピラゾール塩酸塩を得た後、こ
れをパラジウム炭素を用いて接触還元することに
より(6)式の4,5―ジアミノ―1―フエニル―ピ
ラゾールを合成し、次いでこれを水中でグリオキ
シル酸と反応させて(7)式の4,5―ジヒドロ―1
―フエニル―1H―ピラゾロ〔3,4―b〕ピラ
ジン―5―オンを合成し、最後にこれをオキシ塩
化リンと還流することにより得ることができる。 前記(1)式の化合物は、優れた抗腫瘍作用又は抗
ウイルス作用を有し、癌化細胞又はウイルスの増
殖を抑制するため、抗腫瘍剤又は抗ウイルス剤と
して有効に使用される。 以下、本発明化合物(1)の製造例を具体的に示
す。 製造例 1〜27 5―クロロ―1―フエニル―1H―ピラゾロ
〔3,4―b〕ピラジン23.1g(0.1モル)と第1
表に示すアミン又は含窒素複素環4モルとを封管
中220℃で3時間反応させた後、クロロホルムに
溶解する。これを希塩酸、次いで10%炭酸ナトリ
ウム溶液で洗浄し、硫酸ナトリウムで乾燥し、溶
媒を留去する。残渣を第1表に示す再結晶溶媒で
再結晶し、第1表に示す通りの目的化合物を得
た。これら化合物の融点、IRを第2表に示す。
[Formula] (where R 1 and R 2 have the above meanings) A new compound 1-phenyl-1H-pyrazolo [ 3,4-b] found that pyrazine derivatives are obtained, and that these compounds have excellent antitumor or antiviral effects and can be effectively used as antitumor or antiviral agents,
The present invention has been accomplished. The present invention will be explained in more detail below. Novel compound 1-phenyl-1H- according to the present invention
The pyrazolo[3,4-b]pyrazine derivative has the above-mentioned formula (1), i.e. (However, R 1 and R 2 are each a hydrogen atom; an alkyl group; an alkyl group substituted with a hydroxy group, a carboxyl group, a halogen atom, an alkylamino group, a phenyl group, a nitrophenyl group, a halogenophenyl group, or an alkylphenyl group; Cycloalkyl group; cycloalkyl group substituted by an alkyl group; or amino group; or R 1 and R 2 are saturated heterocycles (nitrogen-containing saturated heterocycles) together with the nitrogen atom to which they are bonded, with or without an oxygen atom (The heterocycle may be substituted with a carboxyl group.) Here, in formula (1), the alkyl group includes a straight chain alkyl group such as a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, a 1-methylethyl group, a 2-methylpropyl group, a 1- Methylpropyl group, 1,1-dimethylethyl group, 2-methylbutyl group, 3-methylbutyl group, 1,1-dimethylpropyl group, 2,2-dimethylpropyl group, 1-methylbutyl group, 1-methylpentyl group, 2 -Methylpentyl group, 3-methylpentyl group, 4-methylpentyl group, 1,3-dimethylbutyl group, 1,2-dimethylbutyl group, 2,3-dimethylbutyl group, 2,2-dimethylbutyl group,
Examples include branched alkyl groups such as 3,3-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, 1-methylhexyl group, and 1-methylheptyl group. In addition, as substituted alkyl groups, one or more hydrogen atoms of the above alkyl groups can be substituted with a hydroxy group, a carboxy group, a halogen, a lower alkylamino group,
Examples include those appropriately substituted with a phenyl group and a substituted phenyl group. In this case, examples of halogen include fluorine, chlorine, bromine, etc., and examples of the alkyl group of the lower alkylamino group include methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, pentyl group, and isopentyl group. , a neopentyl group, a hexyl group, and other linear or branched alkyl groups having 1 to 6 carbon atoms. Furthermore, the substituted phenyl group has one or more of its hydrogen atoms replaced with a methyl group, ethyl group, propyl group, isopropyl group,
Linear or branched lower alkyl groups having 1 to 6 carbon atoms such as butyl group, isobutyl group, pentyl group, isopentyl group, neopentyl group, hexyl group, halogens such as fluorine, chlorine, bromine, nitro group, carboxyl group Examples include groups. Furthermore, examples of the cycloalkyl group include a cyclopentyl group and a cyclohexyl group. In addition, a cycloalkyl group has one of its hydrogen atoms.
or two or more of them are methyl group, ethyl group, propyl group,
It may be substituted with a linear or branched lower alkyl group having 1 to 6 carbon atoms, such as an isopropyl group, a butyl group, an isobutyl group, a pentyl group, an isopentyl group, a neopentyl group, a hexyl group, and the like. Furthermore, examples of the nitrogen-containing saturated heterocycle include pyrrolidinyl, imidazolidinyl, pyrazolidinyl, piperidinyl, piperazinyl, morpholinyl, and the like. Note that the heterocycle may be substituted with a carboxyl group. The compound of formula (1) above can be synthesized by reacting 5-halogeno-1-phenyl-1H-pyrazolo[3,4-b]pyrazine with the corresponding amine or nitrogen-containing heterocycle ( (See reaction formula a below). (However, X is a halogen atom, and R 1 and R 2 have the above meanings.) In addition, in formula (2), 5-
Chloro-1-phenyl-1H-pyrazolo[3,4
-b] Pyrazine (formula (2')) is produced by converting 5-amino-1-phenyl-pyrazole-4-carboxylic acid of formula (3), for example, as shown in reaction formula b below.
The 5-amino-1-phenyl-pyrazole of formula (4) was synthesized by heating to 180°C for decarboxylation, and this was reacted with isoamyl nitrite in ethanol in the presence of dry hydrochloric acid to obtain the formula (5). After obtaining 5-amino-4-nitroso-1-phenyl-pyrazole hydrochloride, it was catalytically reduced using palladium carbon to synthesize 4,5-diamino-1-phenyl-pyrazole of formula (6). Then, this was reacted with glyoxylic acid in water to obtain 4,5-dihydro-1 of formula (7).
-Phenyl-1H-pyrazolo[3,4-b]pyrazin-5-one can be synthesized and finally refluxed with phosphorus oxychloride. The compound of formula (1) has excellent antitumor or antiviral effects and suppresses the proliferation of cancerous cells or viruses, and is therefore effectively used as an antitumor or antiviral agent. Hereinafter, a production example of the compound (1) of the present invention will be specifically shown. Production Examples 1 to 27 23.1 g (0.1 mol) of 5-chloro-1-phenyl-1H-pyrazolo[3,4-b]pyrazine and the first
After reacting with 4 moles of the amine or nitrogen-containing heterocycle shown in the table at 220°C in a sealed tube for 3 hours, it is dissolved in chloroform. This is washed with dilute hydrochloric acid and then with 10% sodium carbonate solution, dried over sodium sulfate and evaporated. The residue was recrystallized using the recrystallization solvent shown in Table 1 to obtain the target compounds shown in Table 1. The melting points and IRs of these compounds are shown in Table 2.

【表】【table】

【表】【table】

【表】【table】

【表】【table】

【表】【table】

Claims (1)

【特許請求の範囲】 1 下記式 (但し、R1及びR2は、それぞれ水素原子;アル
キル基;ヒドロキシ基,カルボキシル基,ハロゲ
ン原子,アルキルアミノ基,フエニル基,ニトロ
フエニル基,ハロゲノフエニル基もしくはアルキ
ルフエニル基により置換されたアルキル基;シク
ロアルキル基;アルキル基により置換されたシク
ロアルキル基;又はアミノ基;又はR1とR2はそ
れらが結合する窒素原子と共に酸素原子を介し又
は介することなく飽和複素環を形成しているもの
であり、該複素環にはカルボキシル基が置換して
いてもよい。) で示される1―フエニル―1H―ピラゾロ〔3,
4―b〕ピラジン誘導体。
[Claims] 1. The following formula (However, R 1 and R 2 are each a hydrogen atom; an alkyl group; an alkyl group substituted with a hydroxy group, a carboxyl group, a halogen atom, an alkylamino group, a phenyl group, a nitrophenyl group, a halogenophenyl group, or an alkylphenyl group; Cycloalkyl group; cycloalkyl group substituted by an alkyl group; or amino group; or R 1 and R 2 together with the nitrogen atom to which they are bonded, with or without an oxygen atom, form a saturated heterocycle; 1-phenyl-1H-pyrazolo[3,
4-b] Pyrazine derivative.
JP1722782A 1982-02-05 1982-02-05 11FUENIRUU1HHPIRAZORO * 3 * 44B * PIRAJINJUDOTAI Expired - Lifetime JPH0240671B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP1722782A JPH0240671B2 (en) 1982-02-05 1982-02-05 11FUENIRUU1HHPIRAZORO * 3 * 44B * PIRAJINJUDOTAI
US06/428,016 US4460773A (en) 1982-02-05 1982-09-29 1-Phenyl-1H-pyrazolo [3,4-b]pyrazine derivatives and process for preparing same
DE19823237243 DE3237243A1 (en) 1982-02-05 1982-10-07 1-PHENYL-1H-PYRAZOLO (3,4-B) PYRAZINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1722782A JPH0240671B2 (en) 1982-02-05 1982-02-05 11FUENIRUU1HHPIRAZORO * 3 * 44B * PIRAJINJUDOTAI

Publications (2)

Publication Number Publication Date
JPS58135887A JPS58135887A (en) 1983-08-12
JPH0240671B2 true JPH0240671B2 (en) 1990-09-12

Family

ID=11938058

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1722782A Expired - Lifetime JPH0240671B2 (en) 1982-02-05 1982-02-05 11FUENIRUU1HHPIRAZORO * 3 * 44B * PIRAJINJUDOTAI

Country Status (1)

Country Link
JP (1) JPH0240671B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6317882A (en) * 1986-07-09 1988-01-25 Lion Corp 5-substituted-1H-pyrazolo[3,4-b]pyrazine derivatives and antitumor agents containing the compounds
EP4329881A4 (en) * 2021-04-30 2025-06-11 Vanqua Bio, Inc. SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND THEIR USES

Also Published As

Publication number Publication date
JPS58135887A (en) 1983-08-12

Similar Documents

Publication Publication Date Title
ES2875944T3 (en) Prostacyclin (PG12) receptor modulators useful for treating prostacyclin-related disorders
RU2017736C1 (en) 5,6-dihydro-2-(substituted phenyl)-1,2,4-triazine-3,5-(2h,4h)-diones showing anticoxidial and coxidiostatic activity
RU2014334C1 (en) Derivatives of imidazo(1,2-b)benzothiazole as antagonists of benzodiazepines
ES2298798T3 (en) IMIDAZOPIRIMIDINAS REPLACED FOR THE PREVENTION AND TREATMENT OF CANCER.
JP2018507170A (en) Process for the preparation of diarylthiohydantoin compounds
JP2005516938A5 (en)
JPH04273878A (en) Heterocyclic compound and preparation thereof
JPH0240671B2 (en) 11FUENIRUU1HHPIRAZORO * 3 * 44B * PIRAJINJUDOTAI
CH611615A5 (en) Process for the preparation of novel indole derivatives
EA011406B1 (en) Pyrido pyrimidine derivatives, preparation thereof, therapeutic use thereof for treating cancer
US6423720B1 (en) Pyrimidine compounds and methods for making and using the same
JPH0240672B2 (en) 55FUENIRUAMINOO11FUENIRUU1HHPIRAZORO * 3 * 44B * PIRAJINJUDOTAI
JP2018199640A (en) Caged compound, method for producing caged compound, and expression method
JPH0228143A (en) Amide compound, production thereof and inhibitor of glutamic acid receptor
WO2019242625A1 (en) Method for preparing lenalidomide derivatives
US6573384B1 (en) Process for production of indole derivatives and intermediates therefor
West Michael-Type Addition Reactions of 4-Chloropyrrolo [2, 3-d] pyrimidines
JPS58180486A (en) 5-phenyloxy-1-phenyl-1H-pyrazolo[3,4-b]pyrazine derivative
Volovenko et al. Synthesis and Properties of 2-Amino-6-nitroindoles
Stunić et al. Reaction of 4‐chloro‐3‐nitrocoumarin with glycine and alanine, and the synthesis of 1‐benzopyrano [3, 2‐c] pyrimidine‐3, 5‐dione
RU2412195C2 (en) Novel compounds derived from 5-thioxylose and therapeutic application thereof
SU143810A1 (en) The method of obtaining n-alkoxy derivatives of n'-bis- (beta-chloroethyl) aminomethyl-isobenzene
JP2010090105A (en) 2-benzyl-4-naphthylimidazole compound
JPS63179871A (en) Substituted isoquinoline derivative and antiulcer agent
HK40058729A (en) Pharmaceutical composition comprising: 2-(((1r,4r)-4-(((4-chlorophenyl)(phenyl)carbamoyloxy)methyl)cyclohexyl)methoxy)acetic acid